OWKIN is proud to announce its participation in CARREFOUR PATHOLOGIE 2024. This prestigious event, organized by the French Society of Pathology (SFP), will be held from November 20 to 22, 2024, at the iconic CNIT Forest, Paris la Défense.
PathAI, a leader in AI-powered pathology solutions, is proud to introduce PathExplore™ Fibrosis1 on our AISight® Translational Research platform, a one-of-a-kind AI tool designed to revolutionize fibrosis, collagen, and fiber quantification directly from whole-slide images (WSIs) of hematoxylin and eosin (H&E)-stained tissue. PathExplore™ Fibrosis offers an unprecedented ability to analyze morphology and spatial organization of fibrosis in the tumor microenvironment (TME) directly from routine pathology images at scale, providing new insights into tumor biology and therapeutic response.
Aiforia, a trusted provider of deep learning artificial intelligence (AI) solutions for pathology and Paige, a leader in next-generation AI technology have formed a non-exclusive partnership aimed at integrating Paige’s Diagnostic AI* applications in the AiforiaⓇ Platform to provide customers with outstanding functionality and performance.
Aiosyn’s NephroPath platform was highlighted at ASN Kidney Week 2024 in San Diego, as our partner Physiogenex presented research that leveraged our AI-powered image analysis technology to assess drug efficacy in preclinical kidney models.
Leica Biosystems, a global leader in anatomic pathology, today announced non-enforcement of their Digital Pathology DICOM (Digital Imaging and Communications in Medicine) patent portfolio, to accelerate the usage of DICOM and standardization in Digital Pathology.
Mindpeak, GmbH, the leader in AI-powered pathological solutions, today announced the collaboration with Sagis DX to conduct a spearheading study, assessing the efficacy of the new Mindpeak Onycomycosis AI algorithm.
PathAI, a leader in digital and AI-powered pathology solutions, and VIZIA Diagnostics, a GI- specialized pathology laboratory based in Alpharetta, Georgia, have announced that VIZIA has adopted PathAI’s AISightⓇ1 Image Management System (IMS) and AI technology to advance the precision and operational efficiency of its pathology services.
Two cases (a 6-year-old female entire beagle with suspected bladder neoplasia and a 11-year-old entire male beagle with a severe thickening bladder mucosa) were presented to the primary veterinarians. The samples of urine and bladder mucosa were sent for cytological evaluation to NationWide Laboratories.
Deciphex had the privilege of joining a dynamic AI panel hosted by Novartis Ireland , alongside industry leaders and policymakers, to discuss the future of AI in pathology and Ireland’s role as a potential European AI hub.
The Institute of Molecular Pathology and Immunology of the University of Porto (IPATIMUP), among the leading institutes for clinical digital pathology and research in the European Union, has partnered with Indica Labs to implement digital primary diagnostics with integrated AI-powered image analysis. IPATIMUP selected the HALO AP® enterprise digital pathology platform from Indica Labs for seamless integration of both off-the-shelf and third-party AI.
